Therefore, while the atrogin-1–mediated BiP may not be involved in the loss in fiber integrity seen in DMD, it does contribute to the reduction in muscle function, making this disease axis therapeutically relevant for potentially improving muscle performance in boys with DMD. The gene discussed is HSPA5; the disease is Duchenne muscular dystrophy.